Professor Christine Bundy
PhD, AFBPS C Psychol (Health)
Professor of Health Psychology/Behavioural Medicine; Research Theme Lead - Optimising Well-being in Health and Illness, Management of Long-Term Conditions
- bundyec@cardiff.ac.uk
- +44 (0)29 206 87842
- Room 13.7, Eastgate House, Newport Road, Cardiff, CF24 0AB
- Available for postgraduate supervision
Overview
I am a Health Psychologist specialising in behaviour change, management of health anxiety and well-being research. I have a number of active, externally funded research projects, please see my research page. The areas I research fall broadly into patient facing and staff facing.
Some of the patient facing research I conduct includes applying and evaluating psychological interventions for patients with long-term conditions (particularly complex and multiple conditions). I am currently working with people who have inflammatory skin and joint conditions including psoriasis and psoriatic arthritis and I have developed new measures in this area and I am currently developing a mobile health application for people with serious skin conditions.
Some of the staff focing research includes developing integrated multi-disciplinary services across these long-term conditions that includes psychological support as part of the service provision and I am researching the best service models to address this.
I also provide training to all health professions to deliver good first-line psychological care including using motivational interviewing techniques to support patient engagement, self-management and behaviour change for risk reduction. I am currenly evaluating support for NHS staff reporting moral injury after deployment for the Pandemic response.
I am an experienced PhD supervisor (more than 20 successfuly completed) and a BPS Stage 2 (Doctoral level) Health Psychology trainer. I have successfully supervised five and I am currently supervising three Health Psychology trainees.
I am the Behavioural Scientist advising the Welsh Government Technical Advisory Group, International Intelligence Committee.
Biography
1984 University of Wales (Cardiff) BSc. Hons Psychology
1990 University of Birmingham PhD Psychology
I held lectureship appointments in Dundee University; Bangor University and the University of Manchester. I held a Senior Lectureship and Readership post at the University of Manchester before locating to Cardiff University as a Professor of Behavioural Medicine/ Health Psychology.
Over the last 30 years I have conducted translational research, applying psychology to inform and improve patient care. My focus is on the role of patient beliefs about long-term conditions and how this impacts on their mood and health behaviour through to interventions that enhance motivation for self-management.
That research has been across long-term conditions and over the last 13 years has focussed on complex psoriasis and psoriatic arthritis. I design and deliver psychological interventions for mood management and behaviour change in long-term conditions and train motivational interviewing skills to health care staff as part of their routine consultations.
I was President of the UK Society for Behavioural Medicine until December 2016 and have served on two NICE clinical guideline development groups. I have over 100 peer review publications including four key reports on the development of NHS patient services. I lead or collaborate on NIHR, industry and patient charity funded research awards totalling over £20M.
Professional memberships
BPS Division of Health Psychology member
UK Society for Behavioural Medicine (Immediate Past president)
International Psoriasis Council Counsellor
Academic positions
Reader Behavioural Medicine University of Manchester
Honorary Professor University of Manchester, UK.
Honorary Consultant Psychologist, Salford Royal Foundation Trust and Central Manchester Foundation Trust, UK.
Speaking engagements
I am fully media trained and am registered on the BPS list of experts.
Committees and reviewing
I am a grant and journal reviewer for a number of bodies.
I am a member of the Welsh Government Technical Advisory Board for International Intelligence on the SARS-CoV-2 Pandemic
Publications
2021
- Hewitt, R. M. and Bundy, C. 2021. New technology use needs patient input. British Journal of Dermatology 185(5), pp. 880-881. (10.1111/bjd.20634)
- Pattinson, R. L.et al. 2021. Patient-reported outcome measures in dermatology: a systematic review. Acta Dermato-Venereologica 101(9), article number: adv00559. (10.2340/00015555-3884)
- Garrido-Cumbrera, M.et al. 2021. Impact of axial spondyloarthritis on mental health in Europe: results from the EMAS study. RMD Open 7(3), article number: e001769. (10.1136/rmdopen-2021-001769)
- Garrido-Cumbrera, M.et al. 2021. Gender differences in patient journey to diagnosis and disease outcomes: results from the European Map of Axial Spondyloarthritis (EMAS). Clinical Rheumatology 40(7), pp. 2753-2761. (10.1007/s10067-020-05558-7)
- Gratacós, J.et al. 2021. A 12-point recommendation framework to support advancement of the multidisciplinary care of psoriatic arthritis: a call to action. Joint Bone Spine 88(3), article number: 105175. (10.1016/j.jbspin.2021.105175)
- Hewitt, R. M.et al. 2021. Implementation of the PsoWell™ model for the management of people with complex psoriasis. Acta Dermato-Venereologica 101(4), article number: adv00445. (10.2340/00015555-3802)
- Garrido-Cumbrera, M.et al. 2021. Identifying parameters associated with delayed diagnosis in axial spondyloarthritis: data from the European map of axial spondyloarthritis. Rheumatology, article number: keab369. (10.1093/rheumatology/keab369)
- Augustin, M.et al. 2021. Characteristics and outcomes of patients treated with apremilast in the real world: results from the APPRECIATE study. Journal of the European Academy of Dermatology and Venereology 35(1), pp. 123-134. (10.1111/jdv.16431)
- Barton, A.et al. 2021. Translating research into clinical practice: quality improvement to halve non-adherence to methotrexate. Rheumatology 60(1), pp. 125–131. (10.1093/rheumatology/keaa214)
- Pattinson, R.et al. 2021. Exploring beliefs and distress in patients with facial palsies. Psychology, Health and Medicine (10.1080/13548506.2021.1876891)
- Watts, T.et al. 2021. Supportive interventions to mitigate moral distress among nurses: a mixed methods systematic review and narrative synthesis. Presented at: Public Health Wales Research and Evaluation Conference 2021: Research in action: COVID-19 and beyond, Online, 23 September 2021.
2020
- Hewitt, R.et al. 2020. The importance of source credibility for recruiting underrepresented groups in health research: Insights from the Covid-19 coping survey. Health Psychology Update 29, pp. 48-49.
- Garrido-Cumbrera, M.et al. 2020. Patient‐reported impact of axial spondyloarthritis on working life: results from the EMAS survey. Arthritis Care and Research (10.1002/acr.24426)
- Kleyn, C.et al. 2020. Psoriasis and mental health workshop report: exploring the links between psychosocial factors, psoriasis, neuroinflammation and cardiovascular disease risk. Acta Dermato-Venereologica 100, pp. 1-8., article number: 20. (10.2340/00015555-3375)
- Sadiq, S. A.et al. 2020. Psychological distress and coping following eye removal surgery. Orbit 39(3), pp. 175-182. (10.1080/01676830.2019.1658789)
2019
- Henry, A. L.et al. 2019. Understanding the experience of sleep disturbance in psoriasis:a qualitative exploration using the Common-Sense Model of Self-Regulation. British Journal of Dermatology 180(6), pp. 1397-1404. (10.1111/bjd.17685)
2018
- Keyworth, C.et al. 2018. Does message framing affect changes in behavioural intentions in people with psoriasis? A randomized exploratory study examining health risk communication. Psychology, Health and Medicine 23(7), pp. 763-778. (10.1080/13548506.2018.1427876)
2017
- Howells, L.et al. 2017. Impact of disease severity, illness beliefs, and coping strategies on outcomes in psoriatic arthritis. Arthritis Care & Research 70(2), pp. 295-302. (10.1002/acr.23330)
- Kleyn, E.et al. 2017. Real-world experience with apremilast in patients with psoriasis: interim analysis of 104 patients from the APPRECIATE study. Presented at: Psoriasis Gene to Clinic, 8th International Congress, The Queen Elizabeth II Conference Centre, London, U.K, 30th Nov – 2nd Dec 2017British Journal of Dermatology, Vol. 177. Vol. 5. Wiley-Blackwell pp. E244., (10.1111/bjd.16059)
- Henry, A. L.et al. 2017. A cross-sectional survey of the nature and correlates of sleep disturbance in people with psoriasis. British Journal of Dermatology 177(4), pp. 1052-1059. (10.1111/bjd.15469)
- Nelson, P. A.et al. 2017. 'New to me': changing patient understanding of psoriasis and identifying mechanisms of change. The Pso Well (R) patient materials mixed-methods feasibility study. British Journal of Dermatology 177(3), pp. 758-770. (10.1111/bjd.15574)
- Chisholm, A.et al. 2017. Motivational interviewing-based training enhances clinicians' skills and knowledge in psoriasis: findings from the Pso Well® study. British Journal of Dermatology 176(3), pp. 677-686. (10.1111/bjd.14837)
- Thorneloe, R. J.et al. 2017. Nonadherence to psoriasis medication as an outcome of limited coping resources and conflicting goals: findings from a qualitative interview study with people with psoriasis. British Journal of Dermatology 176(3), pp. 667-676. (10.1111/bjd.15086)
2016
- Theodorakopoulou, E.et al. 2016. Early- and late-onset psoriasis: a cross-sectional clinical and immunocytochemical investigation. British Journal of Dermatology 175(5), pp. 1038-1044. (10.1111/bjd.14886)
- Pattinson, R.et al. 2016. Stress perception impacts on clinical signs of skin ageing and modifies the epigenome. Journal of Investigative Dermatology 136(9), pp. S171., article number: 62. (10.1016/j.jid.2016.06.079)
- Chisholm, A.et al. 2016. Evaluation of the IMPACT study practitioner training intervention: using motivational interviewing to optimize self-management in psoriasis [Abstract]. British Journal of Dermatology 175(S1), pp. 205-205. (10.1111/bjd.14577)
- Bundy, C.et al. 2016. Obesity, low mood, negative beliefs about illness and severity of psoriasis are linked to dysfunctional eating patterns [Abstract]. British Journal of Dermatology 175(S1), pp. 205-206. (10.1111/bjd.14577)
- Henry, A. L.et al. 2016. A survey of sleep disturbance in psoriasis [Abstract]. British Journal of Dermatology 175(S1), pp. 206-206. (10.1111/bjd.14577)
- Nelson, P. A.et al. 2016. Development and evaluation of the IMPACT programme patient resources to increase understanding of psoriasis and its management: a mixed-methods feasibility study [Abstract]. British Journal of Dermatology 175(S1), pp. 210-210. (10.1111/bjd.14577)
- Howells, L.et al. 2016. The role of beliefs, mood, coping strategies, disease severity and quality of life in patients living with psoriatic arthritis [Abstract]. British Journal of Dermatology 175(S1), pp. 53., article number: P62. (10.1111/bjd.14524)
- Ferguson, F.et al. 2016. Diurnal and seasonal variation in psoriasis symptoms [Abstract]. British Journal of Dermatology 175(S1), pp. 50-50., article number: P56. (10.1111/bjd.14524)
- Hudson, J. L.et al. 2016. What are the combined effects of negative emotions and illness cognitions on self-care in people with type 2 diabetes? A longitudinal structural equation model. Psychology and Health 31(7), pp. 873-890. (10.1080/08870446.2016.1156113)
- Bundy, C. 2016. The role of clinicians, patients and social factors in poor adherence: creating new understanding and consultation skills to increase adherence and self-management psoriasis patients. Journal of the European Academy of Dermatology and Venereology 30(S6), pp. 24., article number: P034. (10.1111/jdv.13709)
- Henry, A. L.et al. 2016. Measurement, classification and evaluation of sleep disturbance in psoriasis: a systematic review. PLoS ONE 11(6), article number: e0157843. (10.1371/journal.pone.0157843)
- Bundy, C. 2016. Is education enough to improve quality of life in people with chronic inflammatory skin conditions?. British Journal of Dermatology 174(6), pp. 1179-1179. (10.1111/bjd.14611)
- Chisholm, A.et al. 2016. Distress, misperceptions, poor coping and suicidal ideation in psoriatic arthritis: a qualitative study. Rheumatology 55(6), pp. 1047-1052. (10.1093/rheumatology/kew009)
- Thaci, D.et al. 2016. Improvements in health-related quality of life and symptoms of depression with tofacitinib: results from two randomized phase 3 studies in patients with moderate to severe psoriasis. Journal of the American Academy of Dermatology 74(5:S1), pp. AB255-AB255. (10.1016/j.jaad.2016.02.992)
- Henry, A. L., Bundy, C. and Kyle, S. D. 2016. A call for improved sleep research in psoriasis populations. International Journal of Dermatology 55(5), pp. e312. (10.1111/ijd.13192)
- Betteridge, N.et al. 2016. Promoting patient-centred care in psoriatic arthritis: a multidisciplinary European perspective on improving the patient experience. Journal of the European Academy of Dermatology and Venereology 30(4), pp. 576-585. (10.1111/jdv.13306)
- Schwartz, J.et al. 2016. Getting under the skin: report from the International Psoriasis Council workshop on the role of stress in psoriasis. Frontiers in Psychology 7, article number: 87. (10.3389/fpsyg.2016.00087)
- Chisholm, A.et al. 2016. The role of personal models in clinical management: exploring health care providers' beliefs about psoriasis. British Journal of Health Psychology 21(1), pp. 114-134. (10.1111/bjhp.12148)
2015
- Kitchen, H.et al. 2015. Content development and refinement for a new Patient reported outcome measure for Psoriasis Treatment (PROMPT). Value in Health 18(3), pp. A184-A185. (10.1016/j.jval.2015.03.1067)
- Bundy, C. 2015. Practitioners need input from behavioural medicine specialists. BMJ 2015(315), article number: h5291. (10.1136/bmj.h5291)
- Nelson, P.et al. 2015. The IMPACT Programme in Psoriasis: Phase I - where we are now and future directions. Dermatological Nursing 14(4), pp. 37-44.
- Kitchen, H.et al. 2015. Rasch analysis of a new Patient Reported Outcome Measure for Psoriasis Treatment (PROMPT). Value in Health 18(3), pp. A184-A184. (10.1016/j.jval.2015.03.1066)
I currently have a number of active, externally funded studies including:
1. Developing a mobile health application for people with serious skin conditions the NEW_ID project
2. Measuring impact of living with long-term conditions the GRIDD study
Patient Reported Impact / Outcomes in serious skin conditions - development of a new global measure of impact (GRIPP)
Behaviour change to reduce risk of long-term conditions
3. Psoriasis and specific co-morbidities
Psoriatic Arthritis and behaviour change;
Eating behaviour, obesity & mood in Psoriasis;
The role of sleep, mood & next-day impact on functioning in Psoriasis
3. Supprting Patient Self-Management
Adherence to medicines and health advice
PsoExpect: identifying the role of expectancy outcomes of new psoriasis medication in medicines adherence
PsoWell: a new model for specialist health care provision
4. Health-care Staff Training & Support - Implementation of the PsoWell model
Devloping a team approach to managment in patients with complex psoriasis using a psychological model to support patient behaviour change.
5. Measuring the impact of SARS-CoV-2 pandemic deployment response among Nursing staff in Wales the ASSISTANCE study
Evaluation of a support package for staff reporting moral injury and accessing the HHP service.
Supervision
- Behaviour change
- Medicines adherence
- Dermatology
- Inflammatory conditions
- Patient self-management
Past projects
Since 2011 I have supervised 13 PhD students to successful completion in the areas of psoriasis and long-term conditions.
I am currently supervising studies in: 1. psoriasis including development of a new measure of impact from living with skin conditions, 2. Evaluating the impact of the Covid-19 response to health care staff well-being.
I have successfully supervised five Stage 2 (doctoral) Health Psychology trainees and currenly have three in progress.